Drugs / GIC-1002
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02276768 Comparator | Oct → Dec 2014 | cancer, colonic disorder | gicare Pharma Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GIC-1002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02276768 ↗ |
| Route | Oral | “oral tablet, white-coated, to be taken with water” NCT02276768 ↗ |